Nate Moore

Medical student at @IUMedSchool. Member of the @VanAllenLab. See what I'm up to at

[Eli Van Allen @VanAllenLab]

Our latest - led by @breardon_reardon (applying to PhD programs this fall!) - an open source cancer genomic + transcriptomic clinical interpretation method

Individual variants + “second-order” events + clinical-preclinical actionability returned in a web-based report👇

[Eli Van Allen @VanAllenLab]

Dragging oncology into this century re: user experience to help interpret genomics af the point of care w/ @stacywgray @ecerami #ASCO17

[Nate Moore @nmael]

Milan Radovich: Exploring new ways to get precision medicine therapies to the patients who need them most! #ASCO17 @IUMedSchool @IU_Health

[Nate Moore @nmael]

@jim_bo_ presenting MatchMiner clinical trial matching magic at poster 442 #ASCO17 @ecerami

[Nate Moore @nmael]

@corrie_painter @MichaelODunphy & @Nikhilwagle are on the scene at #ASCO17 discussing direct-to-patient plans for studying angiosarcoma!

[Nate Moore @nmael]

Saud AlDubayan (@s_aldubayan): germline ATM and PALB2 mutations implicated in hereditary colorectal cancer @ #ASCO17!

[Dear Dr. Researcher, PhD @corrie_painter]

Broadie at #ASCO17

[Saud AlDubayan, M.D. د.سعود الدبيان @s_aldubayan]

I will be presenting the major findings from analyzing germline DNA repair defiency in >5000 CRC pts
(tmr 8am @ S404)
#ASCO2017
@VanAllenLab

[Diana Miao @diana_miao]

Epigenetics and IO response at #ASCO17! Learn more tomorrow (6/5) morning Poster 111! @VanAllenLab

[Nate Moore @nmael]

Very creative comparison of big data stats courtesy Sam Volchenboum @ #ASCO17

[Eli Van Allen @VanAllenLab]

Having a fun day at #ASCO17 @dgmacarthur

[Nathan A. Pennell MD, PhD, FASCO @n8pennell]

The male oncologists display their bright colored plumage, hoping to woo collaborators and intimidate rivals! #ASCO17

[Nate Moore @nmael]

Taking a well deserved break from innovating at #Rosestartup2013 ! Can't wait to hear everyone's pitches!

[Nate Moore @nmael]

Ping

[Nate Moore @nmael]

@fredmercury Hi Fred